Showing results (141-150 of 209) with videos related to
Sort By:
Pageof 21
Nano Letters|July 23, 2020
Light-Induced Nanowetting: Erasable and Rewritable Polymer Nanoarrays via Solid-to-Liquid TransitionsKuan-Ting Lin, Yu-Jia Chen, Meng-Ru Huang, et al.The Journal of Cell Biology|November 1, 2006
A novel histone exchange factor, protein phosphatase 2Cgamma, mediates the exchange and dephosphorylation of H2A-H2BHiroshi Kimura, Nanako Takizawa, Eric Allemand, et al.American Journal of Human Genetics|September 1, 2009
A positive modifier of spinal muscular atrophy in the SMN2 geneThomas W Prior, Adrian R Krainer, Yimin Hua, et al.Nature Communications|February 29, 2024
Specificity, synergy, and mechanisms of splice-modifying drugsYuma Ishigami, Mandy S Wong, Carlos Martí-Gómez, et al.Biomed Research International|July 20, 2019
Podoplanin, a Potential Therapeutic Target for Nasopharyngeal CarcinomaYen-Bin Hsu, Chi-Ying F Huang, Kuan-Ting Lin, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|August 4, 2025
Optimizing embryo transfer timing based on serum progesterone levels from a known implantation cohort: A retrospective observational studyWilliam Hao-Yu Lee, Ting-Chi Huang, Kuan-Ting Lin, et al.Cell Discovery|April 20, 2026
ASO-based PKM splice-switching therapy increases anti-CTLA-4 antibody efficacy in pancreatic ductal adenocarcinomaLijie Han, Lina Gan, Balázs Schäfer, et al.Molecular Cell|June 22, 2019
Modeling RNA-Binding Protein Specificity In Vivo by Precisely Registering Protein-RNA Crosslink SitesHuijuan Feng, Suying Bao, Mohammad Alinoor Rahman, et al.Cell|June 10, 2022
Counteracting chromatin effects of a splicing-correcting antisense oligonucleotide improves its therapeutic efficacy in spinal muscular atrophyLuciano E Marasco, Gwendal Dujardin, Rui Sousa-Luís, et al.Genome Research|November 23, 2007
Features of 5'-splice-site efficiency derived from disease-causing mutations and comparative genomicsXavier Roca, Andrew J Olson, Atmakuri R Rao, et al.Pageof 21